To include your compound in the COVID-19 Resource Center, submit it here.

More Phase III Exubera data

Partners Pfizer (PFE), Aventis (AVE) and Inhale (INHL) reported that in a Phase III trial of 309 patients with Type II diabetes who had failed to

Read the full 266 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE